ストックスクリーナーアプリを入手
2.57
8.21%
-0.23
アフターアワーズ：
2.64
0.07
+2.72%
前日終値:
$2.80
開ける：
$2.625
24時間の取引高:
2.79M
Relative Volume:
0.83
時価総額：
$386.45M
収益：
$4.21M
当期純損益:
$-97.67M
株価収益率:
-2.7634
EPS:
-0.93
ネットキャッシュフロー:
$-70.76M
1週間 パフォーマンス:
-5.17%
1か月 パフォーマンス:
-16.83%
6か月 パフォーマンス:
+7.98%
1年 パフォーマンス:
-24.85%
1日の値動き範囲:
$2.56
$2.73
1週間の範囲:
$2.56
$2.86
52週間の値動き範囲:
$2.01
$5.228
Absci Corp Stock (ABSI) Company Profile
Compare ABSI vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ABSI
Absci Corp
|
2.57 | 421.04M | 4.21M | -97.67M | -70.76M | -0.93 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.27 | 123.47B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
766.66 | 83.60B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
748.72 | 46.83B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
318.65 | 43.11B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
297.04 | 34.79B | 4.98B | 69.60M | 525.67M | 0.5198 |
Absci Corp Stock (ABSI) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-08 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2025-10-02 | 開始されました | JP Morgan | Overweight |
| 2025-07-03 | 再開されました | Morgan Stanley | Overweight |
| 2025-01-22 | 開始されました | Needham | Buy |
| 2024-10-02 | 開始されました | Guggenheim | Buy |
| 2024-07-03 | 開始されました | Morgan Stanley | Overweight |
| 2024-03-14 | 開始されました | Scotiabank | Sector Outperform |
| 2023-12-05 | 開始されました | KeyBanc Capital Markets | Overweight |
| 2023-05-04 | 開始されました | H.C. Wainwright | Buy |
| 2022-08-12 | ダウングレード | JP Morgan | Overweight → Underweight |
| 2022-07-18 | 開始されました | Truist | Buy |
| 2022-03-02 | 再開されました | Cowen | Market Perform |
| 2022-02-01 | 開始されました | Berenberg | Buy |
| 2021-11-10 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2021-10-15 | 再開されました | Cowen | Market Perform |
| 2021-08-16 | 開始されました | BofA Securities | Neutral |
| 2021-08-16 | 開始されました | Cowen | Market Perform |
| 2021-08-16 | 開始されました | Credit Suisse | Outperform |
| 2021-08-16 | 開始されました | Stifel | Hold |
すべてを表示
Absci Corp (ABSI) 最新ニュース
Absci Strengthens Clinical Leadership with Appointment of Ransi Somaratne, M.D., FACC, MBA as Chief Medical Officer - The Manila Times
Absci names Ransi Somaratne as chief medical officer - Investing.com
Absci brings former Vertex leader to drive AI-designed therapeutics pipeline - Stock Titan
Absci Conference: Agentic AI Push and ABS-201 Hair-Loss Program Take Center Stage - Yahoo Finance
ABSI Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Activity Recap: Is now the right time to enter Absci Corporation - baoquankhu1.vn
Absci (ABSI) CEO McClain exercises options and withholds shares for taxes - Stock Titan
Absci to Report Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results on March 24, 2026 - The Manila Times
AI drug developer Absci to reveal 2025 results in March webcast - Stock Titan
Absci Corporation (NASDAQ:ABSI) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
ABSI stock up on initiating dosing in androgenetic alopecia study - MSN
ABSI Technical Analysis & ETF Price Forecast - Intellectia AI
Absci to Participate in Upcoming Investor Conferences - 富途牛牛
AI-driven drug developer Absci lines up four March investor events - Stock Titan
In the Wake of Absci Corporation's (NASDAQ:ABSI) Latest US$75m Market Cap Drop, Institutional Owners May Be Forced to Take Severe Actions - 富途牛牛
Insiders Who Purchased US$582.6k Of Absci Stock May Not Have Expected 17% Tumble - simplywall.st
Absci (NASDAQ: ABSI) SVP has shares withheld to cover RSU taxes - Stock Titan
OpenAI considers backing AI-led drug discovery firms: report - Seeking Alpha
Absci Corporation: Drawing Potential Insights On ABS-101 And ABS-201 (NASDAQ:ABSI) - Seeking Alpha
What is Absci Corporation’s valuation compared to sectorFed Meeting & Growth Focused Stock Reports - mfd.ru
Absci Corporation (NASDAQ:ABSI) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Absci Corporation's (NASDAQ:ABSI) recent 12% pullback adds to one-year year losses, institutional owners may take drastic measures - Yahoo Finance
Sentiment Review: Is Charter Communications Inc stock a buy or sellBull Run & AI Forecasted Entry/Exit Points - baoquankhu1.vn
EPS Watch: Can Absci Corporation lead its sector in growth2025 Volatility Report & Safe Capital Allocation Plans - baoquankhu1.vn
H.B. Fuller, Caledonia Mining And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Benzinga
Absci Unveils Origin-1 AI Model, Teases 2025 Hair-Loss Data and Q4 Endometriosis Trial Launch - Yahoo Finance
Absci Corp Presents Business Update at J.P. Morgan Healthcare Conference - TradingView
Analysts Cut Absci (ABSI) Target, Spotlight New Alopecia Therapy in Early Trials - Finviz
10 Best Penny Stocks to Buy for 2026 - Insider Monkey
JonesTrading Maintains Absci Corp(ABSI.US) With Buy Rating, Maintains Target Price $9 - 富途牛牛
Absci (NASDAQ:ABSI) Sees Unusually-High Trading VolumeWhat's Next? - MarketBeat
How Absci Corporation stock benefits from global expansionEarnings Trend Report & Real-Time Market Trend Scan - ulpravda.ru
Will Absci Corporation stock benefit from commodity pricesJuly 2025 Weekly Recap & Real-Time Buy Signal Notifications - Улправда
What dividend safety score for Absci Corporation stockMarket Trend Review & Target Return Focused Picks - Улправда
Published on: 2026-01-08 23:53:06 - ulpravda.ru
Absci (NASDAQ:ABSI) Shares Down 9.1%Here's What Happened - MarketBeat
Morgan Stanley downgrades Absci stock on TL1A setback and higher risk profile - Investing.com Nigeria
Morgan Stanley Downgrades Absci Corp(ABSI.US) to Hold Rating, Cuts Target Price to $4.32 - 富途牛牛
How resilient is Absci Corporation stock in market downturnsEarnings Miss & AI Optimized Trade Strategies - moha.gov.vn
Absci Corporation (ABSI) Reports Q2 Loss, Misses Revenue Estimates - MSN
Absci Corporation (NASDAQ:ABSI) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Absci Corp | 4: Statement of changes in beneficial ownership of securities-Director VAN HOUTEN FRANS - 富途牛牛
Absci Corporation (ABSI) Investor Outlook: Unpacking a 136% Potential Upside in Biotech Innovation - DirectorsTalk Interviews
Absci Unveils Preclinical Data for AI-Designed ABS-201, Targeting a Novel Hormonal Pathway for Hair Loss Treatment - Finviz
Absci Corporation (ABSI) Announces First Participants Dosed In Phase 1/2a HEADLINE Trial - Finviz
Morgan Stanley Assumes Coverage on Absci Corporation (ABSI) with $7 Target - MSN
10 Best Biotech Penny Stocks to Buy According to Analysts - Insider Monkey
Absci Corporation (ABSI) Draws Full Buy Consensus With 150% Upside Potential - Finviz
Absci Corp (ABSI) 財務データ
収益
当期純利益
現金流量
EPS
5.71%
0.02%
大文字化:
|
ボリューム (24 時間):